Observational studyJournal of pediatric gastroenterology and nutrition2026
High prevalence of ultra-short celiac disease in children with low anti-tissue transglutaminase immunoglobulin A levels: The risk of misdiagnosis without bulb biopsy.
Observational study in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesDespite recent advances in diagnostics, celiac disease (CD) diagnosis remains challenging. Ultra-short celiac disease (USCD) has been proposed as a distinct phenotype characterized by villous atrophy confined to the duodenal bulb, positive celiac serology, and clinical features consistent with CD. This study aimed to assess the impact of adherence to European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines, including duodenal bulb biopsy, in the diagnostic process of CD, and to investigate whether omission of bulb sampling may have led to misclassification of potential celiac disease (PCD).
methodsWe conducted a retrospective, observational study of pediatric patients evaluated for CD between June 2017 and December 2024 at a tertiary-care center. Patients undergoing biopsy-based diagnosis were stratified by biopsy protocol: distal duodenum (DII) versus distal duodenum plus bulb (DII + Bulb). A logistic regression model using tissue transglutaminase immunoglobulin A (TTG-IgA) levels as predictor estimated the likelihood of missed USCD among PCD cases in the DII group.
resultsOut of 474 patients undergoing endoscopy, 361 had TTG-IgA <10 × ULN. Of these, 24 were in DII group and 337 in DII + Bulb group. In the latter, 140 (41.5%) were classified as classic CD, 54 (16%) as PCD, and 143 (42.4%) as USCD. PCD detection dramatically dropped after full adherence to guidelines. The logistic model identified seven of nine PCD patients in DII group as likely USCD.
conclusionsSystematic duodenal bulb biopsy significantly improves USCD detection in patients with low TTG-IgA levels. PCD cases diagnosed without bulb sampling warrant reassessment, especially during transition to adult care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.